GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (NSE:SYNGENE) » Definitions » 5-Year Yield-on-Cost %

Syngene International (NSE:SYNGENE) 5-Year Yield-on-Cost % : 0.07 (As of May. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International 5-Year Yield-on-Cost %?

Syngene International's yield on cost for the quarter that ended in Mar. 2024 was 0.07.


The historical rank and industry rank for Syngene International's 5-Year Yield-on-Cost % or its related term are showing as below:

NSE:SYNGENE' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.06   Med: 0.16   Max: 0.28
Current: 0.07


During the past 13 years, Syngene International's highest Yield on Cost was 0.28. The lowest was 0.06. And the median was 0.16.


NSE:SYNGENE's 5-Year Yield-on-Cost % is ranked worse than
97.37% of 152 companies
in the Biotechnology industry
Industry Median: 1.615 vs NSE:SYNGENE: 0.07

Competitive Comparison of Syngene International's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Syngene International's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Syngene International's 5-Year Yield-on-Cost % falls into.



Syngene International 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Syngene International is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Syngene International  (NSE:SYNGENE) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Syngene International 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Syngene International's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (NSE:SYNGENE) Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (NSE:SYNGENE) Headlines

No Headlines